The majority of severe COVID-19 patients develop anti-cardiac autoantibodies.
- Resource Type
- Article
- Source
- GeroScience; Oct2022, Vol. 44 Issue 5, p2347-2360, 14p
- Subject
COVID-19 AUTOANTIBODIES POST-acute COVID-19 syndrome INFLAMMATORY mediators VIRAL antibodies - Language
- ISSN
- 25092715